Prostate cancer treatment with radiotherapy: Maturing methods that minimize morbidity

Alan Pollack, G. K. Zagars, I. I. Rosen

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Technological advances in treatment delivery and planning have provided the backdrop for an unprecedented number of options in the treatment of prostate cancer with radiotherapy. The more common choices include classical external-beam radiotherapy, external-beam radiotherapy using three- dimensional treatment planning and conformal radiotherapy (3DCRT), ultrasound-guided transperineal implant monotherapy alone or in combination with external-beam radiotherapy, and intensity-modulated radiotherapy (IMRT) techniques. This chapter reviews the data from these methods with an emphasis on dose escalation, provides comparisons with prostate-specific antigen (PSA)-era radical prostatectomy series where appropriate, and highlights future initiatives designed to further improve outcome.

Original languageEnglish
Pages (from-to)150-161
Number of pages12
JournalSeminars in Oncology
Volume26
Issue number2
StatePublished - May 18 1999
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Radiotherapy
Morbidity
Conformal Radiotherapy
Intensity-Modulated Radiotherapy
Therapeutics
Prostate-Specific Antigen
Prostatectomy

ASJC Scopus subject areas

  • Oncology

Cite this

Prostate cancer treatment with radiotherapy : Maturing methods that minimize morbidity. / Pollack, Alan; Zagars, G. K.; Rosen, I. I.

In: Seminars in Oncology, Vol. 26, No. 2, 18.05.1999, p. 150-161.

Research output: Contribution to journalArticle

@article{3cf0562d87a7430f877ecbb10d9b8aa2,
title = "Prostate cancer treatment with radiotherapy: Maturing methods that minimize morbidity",
abstract = "Technological advances in treatment delivery and planning have provided the backdrop for an unprecedented number of options in the treatment of prostate cancer with radiotherapy. The more common choices include classical external-beam radiotherapy, external-beam radiotherapy using three- dimensional treatment planning and conformal radiotherapy (3DCRT), ultrasound-guided transperineal implant monotherapy alone or in combination with external-beam radiotherapy, and intensity-modulated radiotherapy (IMRT) techniques. This chapter reviews the data from these methods with an emphasis on dose escalation, provides comparisons with prostate-specific antigen (PSA)-era radical prostatectomy series where appropriate, and highlights future initiatives designed to further improve outcome.",
author = "Alan Pollack and Zagars, {G. K.} and Rosen, {I. I.}",
year = "1999",
month = "5",
day = "18",
language = "English",
volume = "26",
pages = "150--161",
journal = "Seminars in Oncology",
issn = "0093-7754",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Prostate cancer treatment with radiotherapy

T2 - Maturing methods that minimize morbidity

AU - Pollack, Alan

AU - Zagars, G. K.

AU - Rosen, I. I.

PY - 1999/5/18

Y1 - 1999/5/18

N2 - Technological advances in treatment delivery and planning have provided the backdrop for an unprecedented number of options in the treatment of prostate cancer with radiotherapy. The more common choices include classical external-beam radiotherapy, external-beam radiotherapy using three- dimensional treatment planning and conformal radiotherapy (3DCRT), ultrasound-guided transperineal implant monotherapy alone or in combination with external-beam radiotherapy, and intensity-modulated radiotherapy (IMRT) techniques. This chapter reviews the data from these methods with an emphasis on dose escalation, provides comparisons with prostate-specific antigen (PSA)-era radical prostatectomy series where appropriate, and highlights future initiatives designed to further improve outcome.

AB - Technological advances in treatment delivery and planning have provided the backdrop for an unprecedented number of options in the treatment of prostate cancer with radiotherapy. The more common choices include classical external-beam radiotherapy, external-beam radiotherapy using three- dimensional treatment planning and conformal radiotherapy (3DCRT), ultrasound-guided transperineal implant monotherapy alone or in combination with external-beam radiotherapy, and intensity-modulated radiotherapy (IMRT) techniques. This chapter reviews the data from these methods with an emphasis on dose escalation, provides comparisons with prostate-specific antigen (PSA)-era radical prostatectomy series where appropriate, and highlights future initiatives designed to further improve outcome.

UR - http://www.scopus.com/inward/record.url?scp=0032914911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032914911&partnerID=8YFLogxK

M3 - Article

C2 - 10597726

AN - SCOPUS:0032914911

VL - 26

SP - 150

EP - 161

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - 2

ER -